External resources Cleveland Clinic: What happens when patients stop taking GLP-1 drugs Washington University: Stopping GLP-1 drugs can quickly erase cardiovascular benefits NIH: Metabolic rebound after GLP-1 receptor agonist discontinuation (meta-analysis) University of Oxford: Weight loss drug discontinuation and regain trajectories NIH: Discontinuation and reinitiation of GLP-1 receptor agonists among US adults For researchers serious about optimizing their transition off GLP-1 medications, SeekPeptides provides the most comprehensive resource available, with evidence-based guides, proven protocols, community support from thousands of members who have navigated these exact decisions, and expert guidance tailored to individual goals
It signals the pituitary gland to release HGH in a controlled way
GLP-1-related fatigue often presents as: Persistent low energy despite adequate sleep Mental fog or difficulty concentrating Physical weakness or feeling heavy Lack of motivation for usual activities Energy that comes and goes in waves Feeling more tired after eating (or not eating) This type of fatigue tends to feel different from ordinary tiredness and may fluctuate, especially around dose increases, significant dietary changes, or periods of rapid weight loss
Sometimes you need to start with a lower dose and titrate up in a way that fits the patient
Notes: AM/PM routine with strong SPF education
doi: 10.1186/s40168-015-0085-6 13 Norder GrusellEDahlnGRuthMNyLQuiding-JrbrinkMBergquistHet al